Industry Research Reports

Home > Reports > Chemical & Material > Icodextrin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Icodextrin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-21

Pages: 85 Pages

Report ld: 4154037

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Icodextrin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.

North American market for Icodextrin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Icodextrin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Icodextrin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Icodextrin include Baxter, FZBIOTECH, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Icodextrin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Icodextrin by region & country, by Type, and by Application.

The Icodextrin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Icodextrin.

MARKET SEGMENTATION

By Company

Baxter
FZBIOTECH

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

7.5％ Icodextrin
4％ Icodextrin

Segment by Application

Ambulatory Peritoneal Dialysis (CAPD)
Automatic Peritoneal Dialysis (APD)
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Icodextrin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Icodextrin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Icodextrin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Icodextrin Product Introduction

1.2 Global Icodextrin Market Size Forecast

1.2.1 Global Icodextrin Sales Value (2020-2031)

1.2.2 Global Icodextrin Sales Volume (2020-2031)

1.2.3 Global Icodextrin Sales Price (2020-2031)

1.3 Icodextrin Market Trends & Drivers

1.3.1 Icodextrin Industry Trends

1.3.2 Icodextrin Market Drivers & Opportunity

1.3.3 Icodextrin Market Challenges

1.3.4 Icodextrin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Icodextrin Players Revenue Ranking (2024)

2.2 Global Icodextrin Revenue by Company (2020-2025)

2.3 Global Icodextrin Players Sales Volume Ranking (2024)

2.4 Global Icodextrin Sales Volume by Company Players (2020-2025)

2.5 Global Icodextrin Average Price by Company (2020-2025)

2.6 Key Manufacturers Icodextrin Manufacturing Base and Headquarters

2.7 Key Manufacturers Icodextrin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Icodextrin

2.9 Icodextrin Market Competitive Analysis

2.9.1 Icodextrin Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Icodextrin Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icodextrin as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 7.5％ Icodextrin

3.1.2 4％ Icodextrin

3.2 Global Icodextrin Sales Value by Type

3.2.1 Global Icodextrin Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Icodextrin Sales Value, by Type (2020-2031)

3.2.3 Global Icodextrin Sales Value, by Type (%) (2020-2031)

3.3 Global Icodextrin Sales Volume by Type

3.3.1 Global Icodextrin Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Icodextrin Sales Volume, by Type (2020-2031)

3.3.3 Global Icodextrin Sales Volume, by Type (%) (2020-2031)

3.4 Global Icodextrin Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Ambulatory Peritoneal Dialysis (CAPD)

4.1.2 Automatic Peritoneal Dialysis (APD)

4.1.3 Others

4.2 Global Icodextrin Sales Value by Application

4.2.1 Global Icodextrin Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Icodextrin Sales Value, by Application (2020-2031)

4.2.3 Global Icodextrin Sales Value, by Application (%) (2020-2031)

4.3 Global Icodextrin Sales Volume by Application

4.3.1 Global Icodextrin Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Icodextrin Sales Volume, by Application (2020-2031)

4.3.3 Global Icodextrin Sales Volume, by Application (%) (2020-2031)

4.4 Global Icodextrin Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Icodextrin Sales Value by Region

5.1.1 Global Icodextrin Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Icodextrin Sales Value by Region (2020-2025)

5.1.3 Global Icodextrin Sales Value by Region (2026-2031)

5.1.4 Global Icodextrin Sales Value by Region (%), (2020-2031)

5.2 Global Icodextrin Sales Volume by Region

5.2.1 Global Icodextrin Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Icodextrin Sales Volume by Region (2020-2025)

5.2.3 Global Icodextrin Sales Volume by Region (2026-2031)

5.2.4 Global Icodextrin Sales Volume by Region (%), (2020-2031)

5.3 Global Icodextrin Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Icodextrin Sales Value, 2020-2031

5.4.2 North America Icodextrin Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Icodextrin Sales Value, 2020-2031

5.5.2 Europe Icodextrin Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Icodextrin Sales Value, 2020-2031

5.6.2 Asia Pacific Icodextrin Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Icodextrin Sales Value, 2020-2031

5.7.2 South America Icodextrin Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Icodextrin Sales Value, 2020-2031

5.8.2 Middle East & Africa Icodextrin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Icodextrin Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Icodextrin Sales Value

6.2.1 Key Countries/Regions Icodextrin Sales Value, 2020-2031

6.2.2 Key Countries/Regions Icodextrin Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Icodextrin Sales Value, 2020-2031

6.3.2 United States Icodextrin Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Icodextrin Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Icodextrin Sales Value, 2020-2031

6.4.2 Europe Icodextrin Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Icodextrin Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Icodextrin Sales Value, 2020-2031

6.5.2 China Icodextrin Sales Value by Type (%), 2024 VS 2031

6.5.3 China Icodextrin Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Icodextrin Sales Value, 2020-2031

6.6.2 Japan Icodextrin Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Icodextrin Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Icodextrin Sales Value, 2020-2031

6.7.2 South Korea Icodextrin Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Icodextrin Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Icodextrin Sales Value, 2020-2031

6.8.2 Southeast Asia Icodextrin Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Icodextrin Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Icodextrin Sales Value, 2020-2031

6.9.2 India Icodextrin Sales Value by Type (%), 2024 VS 2031

6.9.3 India Icodextrin Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Baxter

7.1.1 Baxter Company Information

7.1.2 Baxter Introduction and Business Overview

7.1.3 Baxter Icodextrin Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Baxter Icodextrin Product Offerings

7.1.5 Baxter Recent Development

7.2 FZBIOTECH

7.2.1 FZBIOTECH Company Information

7.2.2 FZBIOTECH Introduction and Business Overview

7.2.3 FZBIOTECH Icodextrin Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 FZBIOTECH Icodextrin Product Offerings

7.2.5 FZBIOTECH Recent Development

8 Industry Chain Analysis

8.1 Icodextrin Industrial Chain

8.2 Icodextrin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Icodextrin Sales Model

8.5.2 Sales Channel

8.5.3 Icodextrin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Icodextrin Market Trends

Table 2. Icodextrin Market Drivers & Opportunity

Table 3. Icodextrin Market Challenges

Table 4. Icodextrin Market Restraints

Table 5. Global Icodextrin Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Icodextrin Revenue Market Share by Company (2020-2025)

Table 7. Global Icodextrin Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Icodextrin Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Icodextrin Price by Company (2020-2025) & (USD/g)

Table 10. Key Manufacturers Icodextrin Manufacturing Base and Headquarters

Table 11. Key Manufacturers Icodextrin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Icodextrin

Table 13. Global Icodextrin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icodextrin as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Icodextrin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Icodextrin Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Icodextrin Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Icodextrin Sales Market Share in Value by Type (2020-2025)

Table 20. Global Icodextrin Sales Market Share in Value by Type (2026-2031)

Table 21. Global Icodextrin Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Icodextrin Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Icodextrin Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Icodextrin Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Icodextrin Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Icodextrin Price by Type (2020-2025) & (USD/g)

Table 27. Global Icodextrin Price by Type (2026-2031) & (USD/g)

Table 28. Global Icodextrin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Icodextrin Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Icodextrin Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Icodextrin Sales Market Share in Value by Application (2020-2025)

Table 32. Global Icodextrin Sales Market Share in Value by Application (2026-2031)

Table 33. Global Icodextrin Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Icodextrin Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Icodextrin Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Icodextrin Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Icodextrin Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Icodextrin Price by Application (2020-2025) & (USD/g)

Table 39. Global Icodextrin Price by Application (2026-2031) & (USD/g)

Table 40. Global Icodextrin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Icodextrin Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Icodextrin Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Icodextrin Sales Value by Region (2020-2025) & (%)

Table 44. Global Icodextrin Sales Value by Region (2026-2031) & (%)

Table 45. Global Icodextrin Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Icodextrin Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Icodextrin Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Icodextrin Sales Volume by Region (2020-2025) & (%)

Table 49. Global Icodextrin Sales Volume by Region (2026-2031) & (%)

Table 50. Global Icodextrin Average Price by Region (2020-2025) & (USD/g)

Table 51. Global Icodextrin Average Price by Region (2026-2031) & (USD/g)

Table 52. Key Countries/Regions Icodextrin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Icodextrin Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Icodextrin Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Icodextrin Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Icodextrin Sales Volume, (2026-2031) & (Kg)

Table 57. Baxter Company Information

Table 58. Baxter Introduction and Business Overview

Table 59. Baxter Icodextrin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 60. Baxter Icodextrin Product Offerings

Table 61. Baxter Recent Development

Table 62. FZBIOTECH Company Information

Table 63. FZBIOTECH Introduction and Business Overview

Table 64. FZBIOTECH Icodextrin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 65. FZBIOTECH Icodextrin Product Offerings

Table 66. FZBIOTECH Recent Development

Table 67. Key Raw Materials Lists

Table 68. Raw Materials Key Suppliers Lists

Table 69. Icodextrin Downstream Customers

Table 70. Icodextrin Distributors List

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Icodextrin Product Picture

Figure 2. Global Icodextrin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Icodextrin Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Icodextrin Sales Volume (2020-2031) & (Kg)

Figure 5. Global Icodextrin Sales Price (2020-2031) & (USD/g)

Figure 6. Icodextrin Report Years Considered

Figure 7. Global Icodextrin Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Icodextrin Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Icodextrin Revenue in 2024

Figure 10. Icodextrin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 7.5％ Icodextrin Picture

Figure 12. 4％ Icodextrin Picture

Figure 13. Global Icodextrin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Icodextrin Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Icodextrin Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Icodextrin Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Icodextrin Price by Type (2020-2031) & (USD/g)

Figure 18. Product Picture of Ambulatory Peritoneal Dialysis (CAPD)

Figure 19. Product Picture of Automatic Peritoneal Dialysis (APD)

Figure 20. Product Picture of Others

Figure 21. Global Icodextrin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Icodextrin Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Icodextrin Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 24. Global Icodextrin Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Icodextrin Price by Application (2020-2031) & (USD/g)

Figure 26. North America Icodextrin Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Icodextrin Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Icodextrin Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Icodextrin Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Icodextrin Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Icodextrin Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Icodextrin Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Icodextrin Sales Volume (%), (2020-2031)

Figure 38. United States Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 44. China Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 46. China Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 56. India Icodextrin Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Icodextrin Sales Value by Type (%), 2024 VS 2031

Figure 58. India Icodextrin Sales Value by Application (%), 2024 VS 2031

Figure 59. Icodextrin Industrial Chain

Figure 60. Icodextrin Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Icodextrin market? zhanKai

The top companies in the global Icodextrin market are Baxter、FZBIOTECH.

Related Reports

Icodextrin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Icodextrin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 125
USD 3950.00
(Single User License)
Global Icodextrin Market Research Report 2026
The global Icodextrin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 123
USD 2900.00
(Single User License)
Global Icodextrin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Icodextrin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 124
USD 4900.00
(Single User License)
Global Icodextrin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Icodextrin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 67
USD 4250.00
(Single User License)
Global Icodextrin Market Research Report 2025
The global market for Icodextrin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 77
USD 2900.00
(Single User License)
Global Icodextrin Market Insights, Forecast to 2030
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
Global Icodextrin Market Research Report 2024
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published Date: 2024-01-10
Pages: 84
USD 2900.00
(Single User License)

Icodextrin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Icodextrin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 125
USD 3950.00 (Single User License)
Global Icodextrin Market Research Report 2026
The global Icodextrin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 123
USD 2900.00 (Single User License)
Global Icodextrin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Icodextrin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 124
USD 4900.00 (Single User License)
Global Icodextrin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Icodextrin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 67
USD 4250.00 (Single User License)
Global Icodextrin Market Research Report 2025
The global market for Icodextrin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 77
USD 2900.00 (Single User License)
Global Icodextrin Market Insights, Forecast to 2030
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published: 2024-04-07
Pages: 71
USD 4900.00 (Single User License)
Global Icodextrin Market Research Report 2024
Icodextrin (CAS 337376-15-5) is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Published: 2024-01-10
Pages: 84
USD 2900.00 (Single User License)